Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In addition, a significant improvement in the first and second phase of insulin secretion was observed with tirzepatide treatment, as well as an improvement in beta cell function, estimated with beta-cell glucose sensitivity
Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP et al (2005)
These effects were more pronounced than those seen with monospecific GLP-1 or GIP receptor agonists, demonstrating the value of the triple-agonist approach for metabolic research
The drugs help control blood sugar levels and reduce the risk of heart disease in people with type 2 diabetes, and are also approved for prescription to overweight people for weight management.
US$ 22.43
US$ 27.15
US$ 22.90
US$ 22.92
